Assignee
IVERIC BIO INC
US·5 granted patents·7 pending applications·7 citations·filing 2018–2023
Top patents by PatentIndex Score
12 records- 0191US11491176B2Methods for treating or preventing ophthalmological conditionsIVERIC BIO INC·Filed 2022·Granted Nov 8, 2022·2 cites·19 claims
- 0290US11273171B2Methods for treating or preventing ophthalmological conditionsIVERIC BIO INC·Filed 2021·Granted Mar 15, 2022·2 cites·19 claims
- 0382US12016875B2Methods for treating or preventing ophthalmological conditionsIVERIC BIO INC·Filed 2023·Granted Jun 25, 2024·0 cites·10 claims
- 0478US2025000889A1Methods for treating or preventing ophthalmological conditionsIVERIC BIO INC·Filed 2022·Application pending·0 cites
- 0577US11913000B2Aptamer therapeutics useful in the treatment of complement-related disordersIVERIC BIO INC·Filed 2021·Granted Feb 27, 2024·0 cites·10 claims
- 0673US11596667B2Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (IPCV)IVERIC BIO INC·Filed 2018·Granted Mar 7, 2023·3 cites·18 claims
- 0764US2023285575A1Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy secondary to dry amdIVERIC BIO INC·Filed 2023·Application pending·0 cites
- 0864US2024139328A1Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy secondary to dry amdIVERIC BIO INC·Filed 2023·Application pending·0 cites
- 0963US2019381087A1Methods for treating or preventing ophthalmological conditionsIVERIC BIO INC·Filed 2019·Application pending·0 cites
- 1055US2024000889A1Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (ipcv)IVERIC BIO INC·Filed 2023·Application pending·0 cites
- 1155US2022370629A1Anti-c5 agent for treatment of dry age-related macular degeneration (amd) or geographic atrophy secondary to dry amdIVERIC BIO INC·Filed 2020·Application pending·0 cites
- 1244US2023398062A1Methods for treating ophthalmological conditionsIVERIC BIO INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →